Singapore markets closed
Straits Times Index
3,348.87 +12.28 (+0.37%) S&P 500
5,291.03 +13.52 (+0.26%) Dow
38,598.09 -88.23 (-0.23%) Nasdaq
16,855.76 +120.74 (+0.72%) Bitcoin USD
70,061.16 +1,936.50 (+2.84%) CMC Crypto 200
1,502.61 +34.67 (+2.36%)
Sichuan Goldstone Asia Pharmaceutical Inc. (300434.SZ)
Shenzhen - Shenzhen Delayed price. Currency in CNY
Add to watchlist
At close: 03:04PM CST
Currency in CNY
Valuation measures4
| Market cap (intra-day) | 3.43B |
| Enterprise value | 3.08B |
| Trailing P/E | 48.33 |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 3.01 |
| Price/book (mrq) | 1.38 |
| Enterprise value/revenue | 2.67 |
| Enterprise value/EBITDA | 28.39 |
Trading information
Stock price history
| Beta (5Y monthly) | 0.33 |
| 52-week change 3 | -45.98% |
| S&P500 52-week change 3 | 23.49% |
| 52-week high 3 | 16.12 |
| 52-week low 3 | 6.89 |
| 50-day moving average 3 | 8.83 |
| 200-day moving average 3 | 10.57 |
Share statistics
| Avg vol (3-month) 3 | 4.33M |
| Avg vol (10-day) 3 | 3.26M |
| Shares outstanding 5 | 401.74M |
| Implied shares outstanding 6 | 411.17M |
| Float 8 | 173.85M |
| % held by insiders 1 | 61.01% |
| % held by institutions 1 | 1.79% |
| Shares short 4 | N/A |
| Short ratio 4 | N/A |
| Short % of float 4 | N/A |
| Short % of shares outstanding 4 | N/A |
| Shares short (prior month ) 4 | N/A |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.11 |
| Trailing annual dividend yield 3 | 1.29% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | 11 Aug 2020 |
| Last split factor 2 | 1.8:1 |
| Last split date 3 | 12 Oct 2018 |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Mar 2024 |
Profitability
| Profit margin | 6.30% |
| Operating margin (ttm) | 32.04% |
Management effectiveness
| Return on assets (ttm) | 3.48% |
| Return on equity (ttm) | 2.73% |
Income statement
| Revenue (ttm) | 1.15B |
| Revenue per share (ttm) | 2.83 |
| Quarterly revenue growth (yoy) | -13.60% |
| Gross profit (ttm) | N/A |
| EBITDA | 264.38M |
| Net income avi to common (ttm) | 72.56M |
| Diluted EPS (ttm) | 0.18 |
| Quarterly earnings growth (yoy) | -37.40% |
Balance sheet
| Total cash (mrq) | 466.27M |
| Total cash per share (mrq) | 1.16 |
| Total debt (mrq) | 118.21M |
| Total debt/equity (mrq) | 4.70% |
| Current ratio (mrq) | 2.60 |
| Book value per share (mrq) | 6.20 |
Cash flow statement
| Operating cash flow (ttm) | 118.35M |
| Levered free cash flow (ttm) | -48.97M |
© 2024 Yahoo. All rights reserved.